Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Börjesson-Hanson, A.
Right arrow Articles by Skoog, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Börjesson-Hanson, A.
Right arrow Articles by Skoog, I.
Related Collections
Right arrow All Cognitive Disorders/Dementia
Right arrow All epidemiology
Right arrow Cohort studies
Right arrow Natural history studies (prognosis)
Right arrow Risk factors in epidemiology
NEUROLOGY 2007;69:2069-2075
© 2007 American Academy of Neurology

Five-year mortality in relation to dementia and cognitive function in 95-year-olds

Anne Börjesson-Hanson, MD, Deborah Gustafson, PhD and Ingmar Skoog, MD, PhD

From the Neuropsychiatric Epidemiology Unit (A.B.-H., D.G., I.S.), Psychiatry Section, Institute of Neuroscience and Physiology, Sahlgrenska Academy at Göteborg University, Sweden; and Medical College of Wisconsin (D.G.), Milwaukee.

Address correspondence and reprint requests to Dr. Anne Börjesson-Hanson, Neuropsykiatri SU/Mölndal, Wallinsgatan 6, SE-431 41 Mölndal, Sweden anne.borjesson{at}neuro.gu.se

Background: Dementia is a known predictor of mortality, but most studies include small numbers of participants above age 90. The influence of dementia or cognition on mortality in this age group is therefore uncertain.

Objective: To examine 5-year mortality in relation to dementia and cognitive performance at age 95.

Methods: A population sample of 338 individuals examined at age 95 was followed to age 100. Dementia was diagnosed according to DSM–III-R criteria. Cognitive function was measured using the Mini-Mental State Examination (MMSE). Information on severe physical disorders was obtained from the Swedish Hospital Discharge Register, and date of death from the Swedish Population Register.

Results: Five-year mortality was higher in 95-year-olds with dementia than in 95-year-olds without dementia (96% vs 73%; p < 0.0001), even when adjusting for severe physical disorders. A Cox regression analysis with calculation of population attributable risk (PAR), calculated from adjusted relative risks, showed that mortality was predicted by dementia (PAR 42%), cardiac disease (PAR 17%), cancer (PAR 6%), and male sex (PAR 7%), but not by stroke. Among the subjects without dementia, cognitive performance measured using the MMSE (n = 133 with complete tests; 81% of the subjects without dementia) predicted mortality. For each point increase in the MMSE, mortality decreased by 13%.

Conclusions: In 95-year-olds, dementia, as well as cognitive performance in the subjects without dementia, influences mortality. When controlling for other severe medical conditions we found dementia to be the leading cause of deaths among the oldest old. The reason why dementia and cognitive function predict life expectancy requires further elucidation.

Abbreviations: AD = Alzheimer disease; ADL = activities of daily living; AF = atrial fibrillation; AP = angina pectoris; CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease; CPRS = Comprehensive Psychopathological Rating Scale; DSM-III-R = Diagnostic and Statistical Manual of Mental Disorders, third edition, revised; MI = myocardial infarction; MMSE = Mini-Mental State Examination; PAR = population attributable risk; RR = relative risks; VaD = vascular dementia.


Supported by grants from The Swedish Research Council (no. 11267), Swedish Council for Working Life and Social Research (no. 2849, 2835, and 0762), Alzheimer Association USA (no. IIRG-03-6168), Hjalmar Svensson Foundation, and National Institutes of Health/National Institutes on Aging 1R03AG026098-01A1.

Disclosure: The authors report no conflicts of interest.

Received March 12, 2007. Accepted in final form June 5, 2007.




This article has been cited by other articles:


Home page
Arch NeurolHome page
V. Haroutunian, M. Schnaider-Beeri, J. Schmeidler, M. Wysocki, D. P. Purohit, D. P. Perl, L. S. Libow, G. T. Lesser, M. Maroukian, and H. T. Grossman
Role of the Neuropathology of Alzheimer Disease in Dementia in the Oldest-Old
Arch Neurol, September 1, 2008; 65(9): 1211 - 1217.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by AAN Enterprises, Inc.